Almouaalamy N, Banjar L, Alshaikh H, Altowairqi J, Alharbi N, Alghamdi W
Ann Med Surg (Lond). 2023; 85(11):5420-5427.
PMID: 37915654
PMC: 10617909.
DOI: 10.1097/MS9.0000000000001315.
Leonhardt J, Winkler M, Kollikowski A, Schiffmann L, Quenzer A, Einsele H
Front Psychol. 2023; 14:1140693.
PMID: 37484070
PMC: 10357839.
DOI: 10.3389/fpsyg.2023.1140693.
Balneaves L, Watling C, Hayward E, Ross B, Taylor-Brown J, Porcino A
J Natl Cancer Inst. 2021; 114(1):25-37.
PMID: 33769512
PMC: 8755493.
DOI: 10.1093/jnci/djab048.
Tangkiatkumjai M, Boardman H, Walker D
BMC Complement Med Ther. 2020; 20(1):363.
PMID: 33228697
PMC: 7686746.
DOI: 10.1186/s12906-020-03157-2.
Jones E, Nissen L, McCarthy A, Steadman K, Windsor C
Integr Cancer Ther. 2019; 18:1534735419854134.
PMID: 31170844
PMC: 6557018.
DOI: 10.1177/1534735419854134.
Exploring the Use of Complementary and Alternative Medicine in Cancer Patients.
Jones E, Nissen L, McCarthy A, Steadman K, Windsor C
Integr Cancer Ther. 2019; 18:1534735419846986.
PMID: 31072149
PMC: 7242794.
DOI: 10.1177/1534735419846986.
A dual continuum model of the reasons for use of complementary health approaches among overweight and obese adults: findings from the 2012 NHIS.
Upchurch D, Liang L, Sirois F
BMC Complement Altern Med. 2018; 18(1):339.
PMID: 30572881
PMC: 6302527.
DOI: 10.1186/s12906-018-2404-5.
Factors underlying treatment decision-making for localized prostate cancer in the U.S. and Canada: A scoping review using principal component analysis.
Andkhoie M, Meyer D, Szafron M
Can Urol Assoc J. 2018; 13(7):E220-E225.
PMID: 30472985
PMC: 6667325.
DOI: 10.5489/cuaj.5538.
Use of Integrative Oncology, Involvement in Decision-Making, and Breast Cancer Survivor Health-Related Quality of Life in the First 5 Years Postdiagnosis.
Andersen M, Sweet E, Hager S, Gaul M, Dowd F, Standish L
Integr Cancer Ther. 2018; 17(3):636-645.
PMID: 29607686
PMC: 6142088.
DOI: 10.1177/1534735418762543.
Pulled in or pushed out? Understanding the complexities of motivation for alternative therapies use in Ghana.
Gyasi R, Asante F, Yeboah J, Abass K, Mensah C, Siaw L
Int J Qual Stud Health Well-being. 2016; 11:29667.
PMID: 27018431
PMC: 4808739.
DOI: 10.3402/qhw.v11.29667.
[Importance of complementary medicine approaches for patients with prostate cancer].
Gschwendtner K, Klein G, Guthlin C, Holmberg C, Horneber M, Weis J
Urologe A. 2014; 53(11):1600-9.
PMID: 25297489
DOI: 10.1007/s00120-014-3613-2.
Understanding the role of scientific evidence in consumer evaluation of natural health products for osteoarthritis an application of the means end chain approach.
Tsui T, Boon H, Boecker A, Kachan N, Krahn M
BMC Complement Altern Med. 2012; 12:198.
PMID: 23107559
PMC: 3517436.
DOI: 10.1186/1472-6882-12-198.
Complementary and alternative medicine use among older Australian women--a qualitative analysis.
McLaughlin D, Lui C, Adams J
BMC Complement Altern Med. 2012; 12:34.
PMID: 22471758
PMC: 3342907.
DOI: 10.1186/1472-6882-12-34.
Integrated medicine in the management of chronic illness: a qualitative study.
Brien S, Bishop F, Riggs K, Stevenson D, Freire V, Lewith G
Br J Gen Pract. 2011; 61(583):e89-96.
PMID: 21276333
PMC: 3026175.
DOI: 10.3399/bjgp11X556254.
Complementary and alternative medicine use among newly diagnosed prostate cancer patients.
McDermott C, Blough D, Fedorenko C, Arora N, Zeliadt S, Fairweather M
Support Care Cancer. 2010; 20(1):65-73.
PMID: 21120540
DOI: 10.1007/s00520-010-1055-y.
Patient decision-making about complementary and alternative medicine in cancer management: context and process.
Balneaves L, Weeks L, Seely D
Curr Oncol. 2008; 15 Suppl 2:s94-s100.
PMID: 18769576
PMC: 2528558.
DOI: 10.3747/co.v15i0.280.
Motivations for consulting complementary and alternative medicine practitioners: a comparison of consumers from 1997-8 and 2005.
Sirois F
BMC Complement Altern Med. 2008; 8:16.
PMID: 18442414
PMC: 2390516.
DOI: 10.1186/1472-6882-8-16.
Complementary and alternative medicine for menopause: a qualitative analysis of women's decision making.
Hill-Sakurai L, Muller J, Thom D
J Gen Intern Med. 2008; 23(5):619-22.
PMID: 18299942
PMC: 2324155.
DOI: 10.1007/s11606-008-0537-9.
Black cohosh (Cimicifuga racemosa [L.] Nutt.): safety and efficacy for cancer patients.
Walji R, Boon H, Guns E, Oneschuk D, Younus J
Support Care Cancer. 2007; 15(8):913-21.
PMID: 17602247
DOI: 10.1007/s00520-007-0286-z.
Researching complementary and alternative treatments--the gatekeepers are not at home.
Fonnebo V, Grimsgaard S, Walach H, Ritenbaugh C, Norheim A, MacPherson H
BMC Med Res Methodol. 2007; 7:7.
PMID: 17291355
PMC: 1800863.
DOI: 10.1186/1471-2288-7-7.